At the end of 2019, a new disease recognized such as severe acute respiratory syndrome
(SARS), was reported in Wuhan, China. This disease was caused by an unknown SARS …

Introduction The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has
currently caused the pandemic with a high progressive speed and has been considered as …

The highly infectious coronavirus disease 2019 (COVID-19) associated with the pathogenic
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to become a …

The outbreak of COVID-19 started in December 2019 and spread rapidly all over the world.
It became clear that the development of an effective vaccine was the only way to stop the …

The efficacy of the vaccines varies between individuals and populations. The
immunogenicity of the vaccine is influenced by various factors, including host factors …

The persistent coronavirus disease 2019 (COVID-19), characterized by severe respiratory
syndrome, is caused by coronavirus 2 (SARS-CoV-2), and it poses a major threat to public …

When the novel coronavirus was described in late 2019, it could not have been imagined
that within a year, more than 100 vaccine candidates would be in preclinical development …

Introduction Multiple COVID-19 vaccines have been approved and employed in the fight
against the pandemic. However, these vaccines have limited long-term effectiveness against …

The speed of development and the magnitude of efficacy of recently developed vaccines
directed against SARS-CoV-2 has been truly remarkable. This editorial will not summarize …

As of 8 January 2021, there were 86,749,940 confirmed coronavirus disease 2019 (COVID-
19) cases and 1,890,342 COVID-19-related deaths worldwide, as reported by the World …